Shake Shack, Inc. Class A SHAK 深 沪
等待开盘 02-05 09:30:00 美东时间
94.48
+0.810
+0.86%
华盛通- 最 高95.9099
- 今 开93.37
- 成交量 99.81万股
- 最 低 92.315
- 昨 收 93.67
- 总市值 38.03亿
- 52周最高 144.65
- 市盈率 静 409.18
- 换手率 0.00%
- 52周最低 72.93
- 委 比 90.48%
- 总股本 4024.78万
- 历史最高 144.65
- 量 比 0.69
- 振 幅 3.84%
- 历史最低 30.00
- 每 手 1
- 风险率 17.69%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多8 Consumer Discretionary Stocks With Whale Alerts In Today's Session
This whale alert can help traders discover the next big trading opportunities. ...
01-22 01:35
美股大行评级 | 存储再获大行看好！花旗、瑞银和美银齐上调西部数据、希捷科技等公司目标价；PNC金融服务获6家大行上调目标价
今日重点评级关注：HC Wainwright & Co.：维持Soleno Therapeutics"买入"评级，目标价从110美元升至120美元；富国银行：维持Soleno Therapeutics"超配"评级，目标价从106美元升至114美元
01-21 11:42
This Intel Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Tuesday
Top Wall Street analysts changed their outlook on these top names. For a comple...
01-20 19:28
Morgan Stanley Upgrades Shake Shack to Overweight, Raises Price Target to $125
Morgan Stanley analyst Brian Harbour upgrades Shake Shack (NYSE:SHAK) from Equal-Weight to Overweight and raises the price target from $115 to $125.
01-20 18:59
Shake Shack Reports $400M Q4 Revenue Vs $408.98M Est, $1.45B in 2025 Sales Vs $1.45B Est, Guides $1.6–$1.7B for 2026 Vs $1.65B Est
Shake Shack Inc. ("Shake Shack" or the "Company") (NYSE:SHAK) provided a business update for the fiscal fourth quarter and fiscal year ended December 31, 2025 ahead of presenting at the 28th Annual ICR Conference today
01-12 20:29
美股大行评级 | 瑞银上调美光科技目标价从300美元升至400美元；Freedom上调百度目标价从120美元升至160美元
今日重点评级关注：Needham：维持Vaxcyte"买入"评级，目标价从90美元升至110美元；Citizens: 维持LGI Homes"跑赢大市"评级，目标价从85美元升至95美元
01-08 18:33
Barclays Maintains Overweight on Shake Shack, Lowers Price Target to $110
Barclays analyst Jeffrey Bernstein maintains Shake Shack (NYSE:SHAK) with a Overweight and lowers the price target from $115 to $110.
01-08 02:18
Shake Shack removed from Raymond James' 'Favorites List' on softer Q4 trends
Shares of Shake Shack (SHAK) are under modest pressure on Tuesday as the stock was removed from Raymond James’ “Favorites List” as industry headwinds led to “softer trends through Q4.” While the firm ...
2025-12-30 23:25
美股大行评级 | 潜在涨幅101%！12家机构集体上调美光目标价；Insmed、RPM、Vital Farms等遭多家大行下调评级
今日重点评级关注：Ascendiant Capital：维持Society Pass"买入"评级，目标价从22美元升至22.5美元；HC Wainwright & Co.：维持Climb Bio"买入"评级，目标价从9美元升至11美元
2025-12-19 10:15
美股大行评级 | 德银首予Coinbase"买入"评级，目标价340美元；AERO获多家机构首予超配评级；大摩维持苹果"超配"评级，目标价升至315美元
今日重点评级关注：巴克莱：维持Iovance Biotherapeutics"超配"评级，目标价从9美元升至10美元；摩根大通：上调Recursion Pharmaceuticals评级至"超配"，目标价从10美元升至11美元
2025-12-18 10:54
